|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
T2 Biosystems, Inc. (TTOO) |
|
|
$0.17 0.00 (0.00%) as of 4:30 Thu 10/12
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
16,340,000 |
Market
Cap: |
2.84(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.0623 - $0.5911 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile T2 Biosystems is an in vitro diagnostics company and engaged in the detection of sepsis-causing pathogens and antibiotic resistance genes. Co.'s products include: T2Dx® Instrument, which runs diagnostic tests from patient samples; T2Candida® Panel, which is a direct-from-blood test that identifies the lethal form of blood stream infections that cause sepsis candidemia; T2Bacteria® Panel, which is a direct-from-blood test that detects bacterial pathogens associated with sepsis; T2Resistance® Panel, which is a direct-from-blood test that detects resistance genes from both gram-positive and gram-negative pathogens; and T2SARS-CoV-2 Panel, which detect SARS-CoV-2, the coronavirus in patients.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
48,345,798 |
48,364,599 |
Total Sell Value |
$0 |
$0 |
$12,851,221 |
$12,864,540 |
Total People Sold |
0 |
0 |
1 |
5 |
Total Sell Transactions |
0 |
0 |
8 |
18 |
End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Lowery Thomas J. |
Chief Scientific Officer |
|
2018-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
16,370 |
30,412 |
|
- |
|
Mcdonough John |
President & CEO |
|
2018-06-06 |
4 |
D |
$8.53 |
$91,706 |
D/D |
(10,751) |
285,213 |
|
- |
|
Mcdonough John |
President & CEO |
|
2018-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
33,130 |
295,964 |
|
- |
|
Barclay Alec |
SVP, Operations |
|
2018-06-06 |
4 |
D |
$8.53 |
$37,600 |
D/D |
(4,408) |
10,893 |
|
- |
|
Barclay Alec |
SVP, Operations |
|
2018-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
13,583 |
15,301 |
|
- |
|
Gibbs Michael Terrence |
General Counsel |
|
2018-06-06 |
4 |
D |
$8.53 |
$40,134 |
D/D |
(4,705) |
26,705 |
|
- |
|
Gibbs Michael Terrence |
General Counsel |
|
2018-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
14,499 |
31,410 |
|
- |
|
Lapidus Stanley |
Director |
|
2018-06-05 |
4 |
S |
$8.87 |
$53,220 |
D/D |
(6,000) |
32,000 |
|
- |
|
Lapidus Stanley |
Director |
|
2018-06-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,000 |
38,000 |
|
- |
|
Cima Michael J. |
Director |
|
2018-06-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,000 |
207,418 |
|
- |
|
Cumming John W |
Director |
|
2018-06-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,000 |
18,000 |
|
- |
|
Elsbree David B |
Director |
|
2018-06-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,000 |
68,000 |
|
- |
|
Liebman Seymour |
Director |
|
2018-06-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,000 |
18,000 |
|
- |
|
Elsbree David B |
Director |
|
2018-06-01 |
4 |
B |
$7.65 |
$32,321 |
I/I |
4,225 |
10,000 |
2.1 |
- |
|
Lowery Thomas J. |
Chief Scientific Officer |
|
2018-02-09 |
4 |
S |
$4.28 |
$9,425 |
D/D |
(2,202) |
14,042 |
|
- |
|
Mcdonough John |
President & CEO |
|
2018-02-09 |
4 |
S |
$4.28 |
$26,930 |
D/D |
(6,292) |
262,834 |
|
- |
|
Gibbs Michael Terrence |
General Counsel |
|
2018-02-09 |
4 |
S |
$4.28 |
$9,425 |
D/D |
(2,202) |
16,911 |
|
- |
|
Goldman Sachs & Co |
|
|
2018-01-01 |
4 |
A |
$0.00 |
$0 |
I/I |
9,708 |
4,214,164 |
|
- |
|
Jones Adrian M |
|
|
2018-01-01 |
4 |
A |
$0.00 |
$0 |
I/I |
9,708 |
4,214,164 |
|
- |
|
Mcdonough John |
President & CEO |
|
2017-11-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
47,423 |
406,604 |
|
- |
|
Lowery Thomas J. |
Chief Scientific Officer |
|
2017-11-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
58,226 |
|
- |
|
Gibbs Michael Terrence |
General Counsel |
|
2017-11-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,500 |
50,687 |
|
- |
|
Elsbree David B |
Director |
|
2017-11-16 |
4 |
B |
$4.11 |
$6,165 |
I/I |
1,500 |
5,775 |
2.1 |
- |
|
Deptula-Hicks Darlene M |
SVP & Chief Financial Officer |
|
2017-06-06 |
4 |
B |
$3.58 |
$14,320 |
D/D |
4,000 |
4,000 |
2.74 |
- |
|
Spadoro Joanne |
Chief Operations Officer |
|
2017-06-06 |
4 |
B |
$3.50 |
$17,500 |
D/D |
5,000 |
5,589 |
2.74 |
- |
|
349 Records found
|
|
Page 10 of 14 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|